2 studies found for:    23393196 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed A Study of Recombinant Vaccinia Virus to Treat Unresectable Primary Hepatocellular Carcinoma
Condition: Carcinoma, Hepatocellular
Intervention: Genetic: JX-594: Recombinant vaccinia virus (TK-deletion plus GM-CSF)
2 Unknown  A Study of Recombinant Vaccinia Virus Prior to Sorafenib to Treat Unresectable Primary Hepatocellular Carcinoma
Condition: Carcinoma, Hepatocellular
Intervention: Drug: JX-594 followed by sorafenib

Indicates status has not been verified in more than two years